Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Gm1 Gangliosidosis. Strongest funded area: Biomarker / Diagnostics. Largest gap: Basic Science.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
12 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for GM1 gangliosidosis. Existing research activity suggests this may be a viable area for grant applications.
Clinical ResearchPublished, Not NIH-Funded
5 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for GM1 gangliosidosis. Existing research activity suggests this may be a viable area for grant applications.
Basic SciencePublished, Not NIH-Funded
15 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for GM1 gangliosidosis. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(5 grants)
These grants mention Gm1 Gangliosidosis as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(5)
OtherZIACompleted
Pathogenesis Informs Therapy for Glycosphingolipid and Glycoprotein Disorders
Tifft, Cynthia·NATIONAL HUMAN GENOME RESEARCH INSTITUTE
